降低mRNA翻译起始区的稳定性原核非融合表达HAb18GEF

为在大肠杆菌中非融合表达肝癌相关抗原HAb18G胞外区片段（HAb18GEF），将HAb18GEF基因的cDNA插入原核表达载体pET21a+。通过计算机辅助设计，对重组的HAb18GEF/pET21a+的mRNA翻译起始区（TIR）的二级结构和密码子偏性同时进行预测。结果发现其存在稳定的茎环结构和许多稀有密码子。通过优化二级结构和优化密码子偏性二种策略分别来降低HAb18GEF/pET21a+的mRNA翻译起始区（TIR）的稳定性。在不改变氨基酸序列的前提下，利用密码子的简并性，通过非连续定点突变实现这两种优化。将突变前后的重组子经酶切鉴定和测序验证后，转化感受态JM109DE3宿主菌后，随机挑菌37℃下用IPTG诱导表达。SDSPAGE、间接ELISA、Western blot 和细胞分级分离法分析这些重组子的诱导表达情况。RNA dot blot对比分析优化前后目的基因mRNA的量。结果证明，成功地构建了HAb18GEF/pET21a+及其二种优化突变体。仅优化TIR区二级结构或仅优化TIR区密码子偏性均能实现HAb18GEF蛋白的非融合表达，而未优化的重组子不表达任何HAb18GEF。非融合表达产物在大肠杆菌中主要以包涵体形式存在，高达293%。由于过表达和细胞渗漏，培养基和周质腔中也可检测到少许的HAb18GEF。优化二级结构和优化密码子偏性二种策略的HAb18GEF的非融合表达量基本相同。优化前后HAb18GEF转录的mRNA量没有差别。这些结果表明，降低mRNA翻译起始区的稳定性可实现肝癌相关抗原HAb18G胞外区片段在大肠杆菌中的非融合表达。

Non-fused Expression of HAb18GEF by Reducing Stability of Translational Initiation Region in mRNA

To express the extracellular fragement of hepatoma associated antigen HAbl8G(HAb18GEF) in E. coli efficiently in a non-fusing way, the cDNA of HAb18GEF gene was inserted into prokaryotic expression vector pET21a + . The secondary structure and codon adaptation of translational initiation region (TIR, from-30 to + 39) in mRNA of recombinant vector HAb18GEF/ pET21a + was predicted simultaneously by computer-aided design. Stable Stem-Loop structures and many low-usage codons were detected in mRNA-TIR of non-optimized recombinant HAb18GEF/pET21a + vector. The stability of mRNA-TIR in recombinant HAb18GEF/pET21a + vector was reduced with following methods: (1) optimization of secondary structure (2) optimization of codon adaptation. These optimization were realized by non-continual site-directed mutagenesis without changing any amino acid sequence in TIR. After being checked through restriction endonuclease digestion and confirmed through nucleotide sequencing, the pre-optimized and post-optimized recombinant vectors were transformed into competent E. coli JM109-DE3. The resulted recombinant clones were selected randomly and induced by IPTG at 37 degrees C. The induced production of these recombinants was analyzed by SDS-PAGE, indirect ELISA, Western blot, and cell fractionation assay. The amount of HAb18GEF mRNA was also detected by RNA dot blot between pre-optimized recombinant and post-optimized recombinant. The results revealed that recombinant non-fused vectors HAb18GEF/pET21a + were successfully constructed and optimized in the secondary structure and codon adaptation of TIR respectively. The HAb18GEF was expressed efficiently in a non-fusing way in recombinant E. coli by secondary structure optimization or codon adaptation optimization. Whereas, no expression of HAb18GEF was detected in pre-optimized recombinants. The non-fused expression products-HAb18GEF, mainly as inclusion body in E. coli, yielded highly above 29.3%. A trait of expression HAb18GEF was also detected both in intermembrane space and in culture medium due to over-expression and cell leakage. Difference in non-fused expression level of HAb18GEF between secondary structure optimization and codon adaptation optimization was negligible. No difference in amount of transcribed mRNA of HAb18GEF between the pre-optimized and the post-optimized recombinants was detected. To sum up, it's feasible to express hepatoma associated antigen HAb18GEF in a non-fusing way by reducing the stability of TIR in mRNA.